AI Science Tracker

Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking

Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China. · 7 Jun 2024 · chemistry

Discovery

Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking

Source check: Needs source check. Not independent scientific confirmation.

Finding: Discovery of a Novel and Potent LCK Inhibitor for Leukemia Treatment via Deep Learning and Molecular Docking. The PLANET model combined with Schrodinger docking screened for LCK inhibitors. Four candidates identified; the lead had IC50 0.43 nM, antiproliferative effects in T-ALL cells and efficacy in a human T-ALL xenograft. Evidence limits: Selectivity and AI-versus-conventional baseline contribution not assessed (abstract only). Reviewed from Europe PMC abstract only.

Technology: PLANET deep-learning docking scorer with Schrodinger suite

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
The PLANET model combined with Schrodinger docking screened for LCK inhibitors.
Test and result
Four candidates identified; the lead had IC50 0.43 nM, antiproliferative effects in T-ALL cells and efficacy in a human T-ALL xenograft.
Limitation / still unknown
Selectivity and AI-versus-conventional baseline contribution not assessed (abstract only).
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38847742

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse chemistry discoveries.